ResMed acquires Somnoware

SAN DIEGO – ResMed has acquired Somnoware, a sleep management software for physicians and sleep and pulmonary function labs. 

The software streamlines the processes of diagnosing and evaluating a patient’s sleep and respiratory care test results, ordering PAP treatment equipment, setting up appointments, tracking PAP compliance, and electronically providing this information directly into a patient’s electronic health record – all from within one platform. 

“We are thrilled to welcome the Somnoware team to ResMed,” said ResMed Sleep & Respiratory Care President Lucile Blaise. “We're committed to driving wider adoption of Somnoware's open and interoperable platform to help more people with OSA or COPD get the diagnoses and treatment solutions they need. Improving patients’ experience and health outcomes is our common goal.” 

ResMed plans to retain all Somnoware staff, integrate its offerings into the ResMed brand and solution ecosystem, and maintain the open and device-agnostic nature of its offerings so end users can keep interoperating with various testing solutions and place orders for treatment devices and accessories from any supplier. 

“I’m thrilled to join forces with ResMed and embark on a shared mission of guiding people toward better sleep and improved breathing,” said Subath Kamalasan, Somnoware’s cofounder and CEO. “Our partnership will open new avenues to help physicians with the critical task of chronic care management. Together, we are committed to driving innovation and delivering solutions that improve the health of patients with sleep disorders and other chronic respiratory diseases.” 

The transaction’s financial terms were not disclosed and are not material to ResMed’s consolidated financial results.